Paper published in a journal (Scientific congresses and symposiums)
Can we use bone turnover markers as targets for antiresorptive treatment in postmenopausal osteoporosis ? an analysis from two phase 3 clinical trials.
BROWN, J.P.; DAKIN, P.; HADJI, P. et al.
2015In Arthritis and Rheumatology, 67 (S10), p. 515-517
Peer Reviewed verified by ORBi
 

Files


Full Text
can we use bone turnover markers as targets for antiresorptive treatment in postmenopausal osteoporosis. An analysis from two phase 3 clinical trials.pdf
Author postprint (94.56 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
BROWN, J.P.
DAKIN, P.
HADJI, P.
McCLUNG, M.R.
MILLER, P.D.
Reginster, Jean-Yves  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
WAGMAN, R.B.
WANG, A.
McCLOSKEY, E.
Language :
English
Title :
Can we use bone turnover markers as targets for antiresorptive treatment in postmenopausal osteoporosis ? an analysis from two phase 3 clinical trials.
Publication date :
2015
Event name :
2015 ACR/ARHP Annual Meeting
Event organizer :
American College of Rheumatology
Event place :
San Francisco, United States
Event date :
du 6 au 11 novembre 2015
Audience :
International
Journal title :
Arthritis and Rheumatology
ISSN :
2326-5191
eISSN :
2326-5205
Publisher :
Wiley
Volume :
67
Issue :
S10
Pages :
515-517
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 22 December 2015

Statistics


Number of views
65 (5 by ULiège)
Number of downloads
1 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi